4//SEC Filing
Nichols William Garrett 4
Accession 0000950170-25-093035
CIK 0001841387other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:30 PM ET
Size
8.7 KB
Accession
0000950170-25-093035
Insider Transaction Report
Form 4
Nichols Garrett
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-06-30$1.29/sh+781$1,007→ 53,274 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-30−781→ 30,314 totalExercise: $1.29Exp: 2033-04-28→ Common Stock (781 underlying) - Sale
Common Stock
2025-06-30$5.04/sh−781$3,936→ 52,493 total
Footnotes (2)
- [F1]This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.
- [F2]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001618364
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:30 PM ET
- Size
- 8.7 KB